Report Detail
Global and Japan Glutamate Receptor Ionotropic NMDA 2B Market Insights, Forecast to 2026
- RnM4198789 |
- 10 September, 2020 |
- Global |
- 134 Pages |
- QYResearch |
- Pharma & Healthcare
Glutamate Receptor Ionotropic NMDA 2B market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Glutamate Receptor Ionotropic NMDA 2B market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Glutamate Receptor Ionotropic NMDA 2B market is segmented into
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others
Segment by Application, the Glutamate Receptor Ionotropic NMDA 2B market is segmented into
Acute Ischemic Stroke
Autism
Brain Ischemia
Burns
Others
Regional and Country-level Analysis
The Glutamate Receptor Ionotropic NMDA 2B market is analysed and market size information is provided by regions (countries).
The key regions covered in the Glutamate Receptor Ionotropic NMDA 2B market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Glutamate Receptor Ionotropic NMDA 2B Market Share Analysis
Glutamate Receptor Ionotropic NMDA 2B market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glutamate Receptor Ionotropic NMDA 2B business, the date to enter into the Glutamate Receptor Ionotropic NMDA 2B market, Glutamate Receptor Ionotropic NMDA 2B product introduction, recent developments, etc.
The major vendors covered:
BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.
1 Study Coverage
- 1.1 Glutamate Receptor Ionotropic NMDA 2B Product Introduction
- 1.2 Market Segments
- 1.3 Key Glutamate Receptor Ionotropic NMDA 2B Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Type
- 1.4.2 JNJ-0808
- 1.4.3 Neu-2000
- 1.4.4 NP-10679
- 1.4.5 NP-11948
- 1.4.6 Radiprodil
- 1.4.7 Others
- 1.5 Market by Application
- 1.5.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Application
- 1.5.2 Acute Ischemic Stroke
- 1.5.3 Autism
- 1.5.4 Brain Ischemia
- 1.5.5 Burns
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size, Estimates and Forecasts
- 2.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue 2015-2026
- 2.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales 2015-2026
- 2.2 Global Glutamate Receptor Ionotropic NMDA 2B, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Glutamate Receptor Ionotropic NMDA 2B Historical Market Size by Region (2015-2020)
- 2.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Glutamate Receptor Ionotropic NMDA 2B Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Region (2021-2026)
- 2.4.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Region (2021-2026)
3 Global Glutamate Receptor Ionotropic NMDA 2B Competitor Landscape by Players
- 3.1 Global Top Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturers
- 3.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturers (2015-2020)
- 3.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers by Revenue
- 3.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Glutamate Receptor Ionotropic NMDA 2B Revenue in 2019
- 3.2.5 Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Manufacturers
- 3.4 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base Distribution, Product Types
- 3.4.1 Glutamate Receptor Ionotropic NMDA 2B Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Type
- 3.4.3 Date of International Manufacturers Enter into Glutamate Receptor Ionotropic NMDA 2B Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Type (2015-2020)
- 4.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2015-2020)
- 4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2015-2020)
- 4.1.3 Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Type (2021-2026)
- 4.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Type (2021-2026)
- 4.2.3 Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Application (2015-2020)
- 5.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2015-2020)
- 5.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2015-2020)
- 5.1.3 Glutamate Receptor Ionotropic NMDA 2B Price by Application (2015-2020)
- 5.2 Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Application (2021-2026)
- 5.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
- 6.1 Japan Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2015-2026
- 6.1.1 Japan Glutamate Receptor Ionotropic NMDA 2B Sales YoY Growth 2015-2026
- 6.1.2 Japan Glutamate Receptor Ionotropic NMDA 2B Revenue YoY Growth 2015-2026
- 6.1.3 Japan Glutamate Receptor Ionotropic NMDA 2B Market Share in Global Market 2015-2026
- 6.2 Japan Glutamate Receptor Ionotropic NMDA 2B Market Size by Players (International and Local Players)
- 6.2.1 Japan Top Glutamate Receptor Ionotropic NMDA 2B Players by Sales (2015-2020)
- 6.2.2 Japan Top Glutamate Receptor Ionotropic NMDA 2B Players by Revenue (2015-2020)
- 6.3 Japan Glutamate Receptor Ionotropic NMDA 2B Historic Market Review by Type (2015-2020)
- 6.3.1 Japan Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2015-2020)
- 6.3.2 Japan Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2015-2020)
- 6.3.3 Japan Glutamate Receptor Ionotropic NMDA 2B Price by Type (2015-2020)
- 6.4 Japan Glutamate Receptor Ionotropic NMDA 2B Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 Japan Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Type (2021-2026)
- 6.4.2 Japan Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Type (2021-2026)
- 6.4.3 Japan Glutamate Receptor Ionotropic NMDA 2B Price Forecast by Type (2021-2026)
- 6.5 Japan Glutamate Receptor Ionotropic NMDA 2B Historic Market Review by Application (2015-2020)
- 6.5.1 Japan Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2015-2020)
- 6.5.2 Japan Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2015-2020)
- 6.5.3 Japan Glutamate Receptor Ionotropic NMDA 2B Price by Application (2015-2020)
- 6.6 Japan Glutamate Receptor Ionotropic NMDA 2B Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 Japan Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Application (2021-2026)
- 6.6.2 Japan Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Application (2021-2026)
- 6.6.3 Japan Glutamate Receptor Ionotropic NMDA 2B Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2015-2026
- 7.2 North America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
- 7.2.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2015-2020)
- 7.2.2 North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2015-2026
- 8.2 Europe Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
- 8.2.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country
- 8.2.2 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
- 9.2.1 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2015-2026
- 10.2 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
- 10.2.1 Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country
- 10.2.2 Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country
- 11.2.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 BioCrea GmbH
- 12.1.1 BioCrea GmbH Corporation Information
- 12.1.2 BioCrea GmbH Description and Business Overview
- 12.1.3 BioCrea GmbH Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Products Offered
- 12.1.5 BioCrea GmbH Recent Development
- 12.2 Bristol-Myers Squibb Company
- 12.2.1 Bristol-Myers Squibb Company Corporation Information
- 12.2.2 Bristol-Myers Squibb Company Description and Business Overview
- 12.2.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Products Offered
- 12.2.5 Bristol-Myers Squibb Company Recent Development
- 12.3 Cerecor Inc.
- 12.3.1 Cerecor Inc. Corporation Information
- 12.3.2 Cerecor Inc. Description and Business Overview
- 12.3.3 Cerecor Inc. Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Products Offered
- 12.3.5 Cerecor Inc. Recent Development
- 12.4 Johnson & Johnson
- 12.4.1 Johnson & Johnson Corporation Information
- 12.4.2 Johnson & Johnson Description and Business Overview
- 12.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Products Offered
- 12.4.5 Johnson & Johnson Recent Development
- 12.5 Luc Therapeutics, Inc.
- 12.5.1 Luc Therapeutics, Inc. Corporation Information
- 12.5.2 Luc Therapeutics, Inc. Description and Business Overview
- 12.5.3 Luc Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Products Offered
- 12.5.5 Luc Therapeutics, Inc. Recent Development
- 12.6 NeurOp, Inc
- 12.6.1 NeurOp, Inc Corporation Information
- 12.6.2 NeurOp, Inc Description and Business Overview
- 12.6.3 NeurOp, Inc Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Products Offered
- 12.6.5 NeurOp, Inc Recent Development
- 12.7 Novartis AG
- 12.7.1 Novartis AG Corporation Information
- 12.7.2 Novartis AG Description and Business Overview
- 12.7.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Products Offered
- 12.7.5 Novartis AG Recent Development
- 12.8 UCB S.A.
- 12.8.1 UCB S.A. Corporation Information
- 12.8.2 UCB S.A. Description and Business Overview
- 12.8.3 UCB S.A. Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Products Offered
- 12.8.5 UCB S.A. Recent Development
- 12.11 BioCrea GmbH
- 12.11.1 BioCrea GmbH Corporation Information
- 12.11.2 BioCrea GmbH Description and Business Overview
- 12.11.3 BioCrea GmbH Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Products Offered
- 12.11.5 BioCrea GmbH Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Glutamate Receptor Ionotropic NMDA 2B Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Glutamate Receptor Ionotropic NMDA 2B Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Glutamate Receptor Ionotropic NMDA 2B. Industry analysis & Market Report on Glutamate Receptor Ionotropic NMDA 2B is a syndicated market report, published as Global and Japan Glutamate Receptor Ionotropic NMDA 2B Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Glutamate Receptor Ionotropic NMDA 2B market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
